CONDENSED ABSTRACT
Sudden cardiac death (SCD) is the primary driver of mortality in
patients with end-stage renal disease (ESRD). Historically, SCD has been
assumed to be due to fatal ventricular arrhythmias (VAs), but recent
data has suggested bradyarrhythmias and asystole may actually play a
larger role than previously suspected. We compared cardiac implantable
electronic device (CIED) interrogation data in ESRD and non-ESRD
patients and found no differences in VA burden between groups.
Additionally, control patients were more likely to require device
therapies. Thus, VA events may play a smaller role in SCD in ESRD
patients than previously assumed.